tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jessica Fye, 81 are a HOLD (34.91%), 128 are a BUY (55.17%), 23 are a SELL (9.91%).
Analyst Jessica Fye, currently employed at JPMORGAN, carries an average stock price target met ratio of 74.64% that have a potential upside of 21.61% achieved within 142 days.
Jessica Fye’s has documented 444 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 30-Oct-2024.
Analyst best performing recommendations are on STOK (STOKE THERAPEUTICS).
The best stock recommendation documented was for STOK (STOKE THERAPEUTICS) at 3/26/2024. The price target of $13 was fulfilled within 1 day with a profit of $2.71 (26.34%) receiving and performance score of 263.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
11 months 19 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-0.07 (-6.54%)
$5
1 years 14 days ago
(25-Oct-2023)
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
$1
$-0.07 (-6.54%)
$3.5
1 years 3 months 20 days ago
(19-Jul-2023)
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
$1.25
$0.18 (16.82%)
$2
1 years 3 months 20 days ago
(19-Jul-2023)
2/5 (40%)
$0.17 (15.74%)
215
Buy
$10
2 years 4 months 17 days ago
(22-Jun-2022)
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Jessica Fye is most bullish on?
Which stock is Jessica Fye is most reserved on?
What Year was the first public recommendation made by Jessica Fye?
